Heidi H Kong MD MHSc

Investigator

10 Center DrBuilding 10, Room 12n238Bethesda, MD 20892
Phone+1 301-402-7452

Dr. Kong is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kong's full profile Already have an account?

Education & Training

National Institutes of Health Clinical CenterResidency, Dermatology, 2005 - 2007
Duke University HospitalResidency, Dermatology, 2002 - 2005
Baylor College of MedicineInternship, Transitional Year, 2001 - 2002
Baylor College of MedicineClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2005 - 2028
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity Start of enrollment: 2007 May 25
COMPLETED
PHASE1
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Apr 21
TERMINATED
PHASE1
Effects of Treatments on Atopic Dermatitis Start of enrollment: 2012 Sep 18
RECRUITING
PHASE2

Publications & Presentations

PubMed

Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy.
Cornelia D Cudrici, Shubham Goel, Keiko Sakamoto, Seon-Pil Jin, Akiko Sekiguchi
Cell Reports. Medicine. 2026-08-18
Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.
Alexandra F Freeman, Chen Wang, Amanda Urban, Iris Martin, Lauren Dang
The Journal of Allergy and Clinical Immunology. 2026-08-01
Shotgun Metagenomics Reveals Skin Microbiome Composition and Function in Infant Atopic Disease.
Zeyang Shen, Jana K Eckert, Richard Saffery, Katrina J Allen, Audrey Walsh
Allergy. 2026-07-17

Journal Articles

Next Steps in Studying the Human Microbiome and Health in Prospective Studies, Bethesda, MD, May 16–17, 2017
J Gregory Caporaso, Martin Blaser, Michael J Orlich, Mitchell H Gail, Heidi H Kong, Andrew T Chan, Kathy Helzlsouer, BioMed Central

Lectures

Atopic Dermatitis
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
Inflammation, Microbiota, and Cancer
Frederick National Laboratory for Cancer Research, Bethesda, Maryland - 9/19/2013

Press Mentions

Atopic Dermatitis Associated with Different Bacteria Depending on Disease SeveritySeptember 7th, 2017
Your Skin Bacteria Fingerprint, and How It WorksMay 8th, 2016
Feet Host to 80 Types of Fungi, Study SaysMay 24th, 2013

Grant Support

Studies Of Skin Microflora In Healthy Individuals And Atopic Dermatitis PatientsNational Cancer Institute2010–2011
Phase I Study Of Topical Romidepsin In Early Stage Cutaneous T-Cell LymphomaNational Cancer Institute2010–2011
Gene Expression Profiling And Clinical Characterization Of PhototoxicityNational Cancer Institute2010–2011
Cutaneous Adverse Drug ReactionsNational Cancer Institute2010–2011
Botulinum Toxin For Painful Cutaneous LeiomyomasNational Cancer Institute2010–2011